Voltage-gated calcium channels and N-methyl-D-aspartate receptors (VGCCs and NMDARs)

Voltage-gated calcium channels (VGCCs) and N-methyl-D-aspartate (NMDA) receptors represent two fundamental yet distinct mechanisms for calcium entry into cells, particularly within the central nervous system. VGCCs are transmembrane proteins that open in response to membrane depolarization, allowing calcium ions to trigger neurotransmitter release, muscle contraction, and gene expression (Catterall, 2011). In contrast, NMDA receptors are ligand-gated ion channels activated by the excitatory neurotransmitter glutamate, playing a pivotal role in synaptic plasticity, learning, and memory (Paoletti et al., 2013). Although they operate via different gating mechanisms, they often function synergistically to regulate intracellular calcium homeostasis and downstream signaling cascades (Stanika et al., 2012). Pathological overactivation of either system can lead to excessive calcium influx, resulting in excitotoxicity and neuronal death, which is a hallmark of conditions such as stroke and neurodegenerative diseases like Alzheimer's (Zamponi et al., 2015). Consequently, they are major therapeutic targets for drugs such as gabapentinoids, calcium channel blockers, and NMDA antagonists like memantine and ketamine (Traynelis et al., 2010). This specific entry is considered incorrect for structured data as it combines two distinct protein families into a single target definition.

Other names

VGCC and NMDA receptorCalcium channels and glutamate receptorsVoltage-dependent calcium channels and N-methyl-D-aspartate receptorsVoltage-gated calcium channel and NMDA receptor complex

Inhibition of calcium ion influx through voltage-dependent or ligand-gated mechanisms to modulate neuronal excitability and vascular tone.